This refresh
Data-driven refresh June 3, 2026. Top 5 per bucket by live Bull Rankings score across a 5182-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2530 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative authored by Groq (with Gemini and data-driven fallbacks). Intraday re-ranking from a top-30 per-bucket shortlist.
Growth — high-quality compounders
1. KGC — Kinross Gold Corporation · score 99
Gold · price $28.17 · 1Y $41.36 · 5Y $45.37 · 10Y $66.69
FCF $3.0b B · Rev +36.9% A · D/E 0.08 A- · P/E 12.0x A- · PEG 1.12 B+
Why now. Kinross Gold Corporation, a mid-cap gold miner, is poised for growth driven by its 36.9% revenue growth rate and $3.0b in free cash flow, with a 12 P/E ratio indicating reasonable valuation. The company's current price of $28.17 and analyst consensus 1-yr target of $41.36 suggest a potential upside, with the 1.67 mean analyst recommendation supporting a 'buy' stance.
Moat. Kinross Gold Corporation's moat stems from its 35.5% ROE, driven by its 36% profit margin, which is a result of its cost advantages in the gold mining sector. The company's diversified production geographies and 4.2 PS ratio indicate a stable business model, allowing it to maintain its market position.
Risk. The main risks for Kinross Gold Corporation include its 1.37 beta, indicating higher volatility, and a 0.08 debt-to-equity ratio, which, although low, may still pose a risk if the company's cash flow decreases. Additionally, the gold mining sector is subject to fluctuations in gold prices, which could impact the company's revenue and profitability.
Horizon. 1-3 yr $41.36 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $45.37 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $66.69 if current growth sustains into durable earnings power.
2. FSM — Fortuna Mining Corp. · score 97
Gold · price $9.42 · 1Y $10.83 · 5Y $15.17 · 10Y $22.30
FCF $563m C+ · Rev +39.8% A · D/E 0.11 A- · P/E 8.7x A · PEG n/a
Why now. Fortuna Mining Corp., a growth-oriented gold mining company, is currently trading at a $9.42 price point with a 8.7 P/E ratio, indicating a relatively low valuation. The company's 39.8% revenue growth rate and 31.1% profit margin suggest a strong growth trajectory, driven by its ability to generate significant free cash flow of $563m. With an analyst consensus target of $14, there is potential for significant upside.
Moat. Fortuna Mining Corp.'s durable competitive advantage stems from its 22% ROE, which is driven by its pricing power as a mid-cap precious-metals miner with diversified production geographies. The company's 2.6 PS ratio and 0.11 debt-to-equity ratio indicate a relatively low valuation and a healthy balance sheet, allowing it to invest in its operations and maintain its market position.
Risk. The main risks facing Fortuna Mining Corp. include its high 2.09 beta, indicating a high level of volatility, and the potential for 39.8% revenue growth to slow down. Additionally, the company's $2.9b market cap and 8.7 P/E ratio may not provide a significant margin of safety in the event of a downturn.
Horizon. 1-3 yr $10.83 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $15.17 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $22.30 if current growth sustains into durable earnings power.
3. DLO — DLocal Limited · score 96
Software - Infrastructure · price $11.40 · 1Y $17.35 · 5Y $18.36 · 10Y $26.99
FCF $374m C · Rev +46.6% A · D/E 0.20 B+ · P/E 17.8x A- · PEG n/a
Why now. DLocal Limited, a software infrastructure company, is currently trading at a $11.40 price point with a 17.8 P/E ratio, indicating a reasonable valuation. The company's 46.6% revenue growth rate and $374m free cash flow suggest a strong growth trajectory. As a growth company, DLocal's high revenue growth rate is driven by its expanding customer base and increasing demand for its services, with a 15.8% profit margin and 35% ROE.
Moat. DLocal's durable competitive advantage stems from its high ROE, which can be attributed to its 35% return on equity. This is a result of the company's ability to maintain a 15.8% profit margin, indicating pricing power in its sector. Additionally, the company's 2.8 price-to-sales ratio suggests a reasonable valuation relative to its revenue.
Risk. DLocal faces risks related to its 1.02 beta, indicating a relatively high market risk. Additionally, the company's 0.2 debt-to-equity ratio, although relatively low, still poses a risk if the company's cash flow were to decline. Furthermore, the company's reliance on a single sector, software infrastructure, may expose it to industry-specific risks.
Horizon. 1-3 yr $17.35 (analyst consensus (n=10)) — fundamentals + valuation re-rating. 5 yr $18.36 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $26.99 if current growth sustains into durable earnings power.
4. PICS — PicS N.V. · score 96
Software - Infrastructure · price $9.03 · 1Y $21.21 · 5Y $14.54 · 10Y $21.38
FCF $167m C · Rev +65.0% A · D/E 0.41 B · P/E 5.4x A · PEG n/a
Why now. PicS N.V., a software infrastructure company, is currently trading at a $9.03 price point with a 65% revenue growth rate and a 10.6% profit margin. The company's free cash flow of $167m and return on equity of 40.4% demonstrate its ability to generate cash and drive growth. With an analyst consensus 1-yr target of $21.21, the setup is attractive for investors looking for growth opportunities.
Moat. PicS N.V.'s durable competitive advantage stems from its ability to maintain a 40.4% return on equity, driven by its pricing power in the software infrastructure sector. The company's 10.6% profit margin and $167m free cash flow also contribute to its moat, allowing it to invest in growth initiatives and maintain its market position. Additionally, the company's 0.41 debt-to-equity ratio provides a stable financial foundation.
Risk. The main risks facing PicS N.V. include its 0.41 debt-to-equity ratio, which, although relatively stable, still poses a risk if the company is unable to manage its debt obligations. Furthermore, the company's 5.4 price-to-earnings ratio may be considered elevated, potentially making it vulnerable to market volatility. Additionally, the company's reliance on growth to drive its valuation may pose a risk if it is unable to maintain its current growth trajectory.
Horizon. 1-3 yr $21.21 (analyst consensus (n=9)) — fundamentals + valuation re-rating. 5 yr $14.54 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $21.38 if current growth sustains into durable earnings power.
5. GPOR — Gulfport Energy Corporation · score 95
Oil & Gas E&P · price $168.82 · 1Y $242.00 · 5Y $271.89 · 10Y $399.66
FCF $362m C · Rev +42.5% A · D/E 0.46 B · P/E 5.6x A · PEG n/a
Why now. Gulfport Energy Corporation, an Oil & Gas E&P company, is currently trading at $168.82 with a P/E of 5.6, indicating undervaluation. The company has a revenue growth rate of 42.5% and a profit margin of 42.1%, driven by its position in the growth category. With an analyst consensus 1-yr target of $242, the stock has potential for upside.
Moat. Gulfport Energy Corporation's ROE of 34% can be attributed to its ability to generate high profits from its oil and gas operations, likely due to its cost advantages and efficient business model. The company's debt-to-equity ratio of 0.46 also suggests a relatively stable financial position, allowing it to invest in growth opportunities. Its position in the Oil & Gas E&P sector provides a foundation for long-term profitability.
Risk. One of the key risks for Gulfport Energy Corporation is its beta of 0.46, which, although relatively low, still indicates some level of market volatility risk. Additionally, the company's debt-to-equity ratio of 0.46 could become a concern if the energy market experiences a downturn, affecting its ability to service debt. The analyst recommendation mean of 1.85 also suggests that while the stock is favored, there may be some variation in analyst opinions regarding its future performance.
Horizon. 1-3 yr $242.00 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $271.89 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $399.66 if current growth sustains into durable earnings power.
Value — quality at a discount
1. AU — AngloGold Ashanti plc · score 100
Gold · price $89.85 · 1Y $123.29 · 5Y $120.24 · 10Y $153.48
FCF $4.2b B · Rev +70.8% A · D/E 0.22 B+ · P/E 13.2x A- · PEG 0.78 A-
Why now. AngloGold Ashanti plc, a mid-cap gold miner, is undervalued given its 70.8% revenue growth rate and $4.2b in free cash flow, which translates to a 9.2% FCF yield. The company's current price of $89.85 and P/E of 13.2 suggest a re-rating catalyst could be the analyst consensus 1-yr target of $123.29. With a 31.1% profit margin, the business has demonstrated its ability to generate earnings.
Moat. AngloGold Ashanti's 43% ROE is driven by its ability to maintain a high profit margin in the gold mining sector, which is characterized by high operating costs and commodity price volatility. The company's diversified production geographies and 0.22 debt-to-equity ratio contribute to its financial stability and flexibility. As a category leader in gold mining, AngloGold Ashanti benefits from its scale and cost advantages.
Risk. The main risks facing AngloGold Ashanti include the volatility of gold prices, which can impact revenue and profitability, and the 0.62 beta, indicating a moderate level of market risk. Additionally, the company's 13.2 P/E ratio is relatively low compared to its growth rate, but a potential re-rating could be limited by the 4.1 price-to-sales ratio, which may indicate a relatively high valuation multiple.
Horizon. 1-3 yr $123.29 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $120.24 at ~6% CAGR — dividend + buyback compounding. 10 yr $153.48 if the moat survives secular pressure.
2. INCY — Incyte Corporation · score 98
Biotechnology · price $97.98 · 1Y $107.96 · 5Y $131.12 · 10Y $167.36
FCF $1.4b C+ · Rev +21.2% A- · D/E 0.01 A · P/E 13.8x A- · PEG 0.36 A
Why now. Incyte Corporation, a biotechnology company, is currently undervalued with a 13.8 P/E ratio and a 0.36 PEG ratio, indicating a potential for re-rating. The company's 21.2% revenue growth rate and $1.4b free cash flow suggest a strong financial foundation. With an analyst consensus 1-yr target of $107.96, the stock has a clear near-term catalyst.
Moat. Incyte's durable competitive advantage stems from its high 30.8% ROE, driven by its 26.7% profit margin, which is a result of its strong positioning in the biotechnology sector. The company's low 0.01 debt-to-equity ratio and 0.8 beta also contribute to its stability and attractiveness.
Risk. The main risks facing Incyte include its reliance on a few key products, the potential for regulatory changes, and the 0.8 beta, which may indicate some volatility. Additionally, the company's 13.8 P/E ratio, although relatively low, may not fully account for potential risks, and the 0.36 PEG ratio may not be sustainable if growth slows.
Horizon. 1-3 yr $107.96 (analyst consensus (n=24)) — multiple re-rating thesis requires a catalyst. 5 yr $131.12 at ~6% CAGR — dividend + buyback compounding. 10 yr $167.36 if the moat survives secular pressure.
3. PDD — PDD Holdings Inc. · score 98
Internet Retail · price $85.40 · 1Y $120.43 · 5Y $114.28 · 10Y $145.88
FCF $15.8b A- · Rev +9.7% B · D/E 0.01 A · P/E 9.0x A · PEG 0.82 B+
Why now. PDD Holdings Inc., an internet retail company, presents an attractive setup with a current price of $85.40, a P/E of 9, and a 21.6% profit margin. The company's $15.8B in free cash flow and 25.4% ROE are notable, driven by its position in the internet retail sector. With an analyst consensus 1-yr target of $120.43, the stock appears undervalued.
Moat. PDD's durable competitive advantage stems from its high ROE, driven by its 21.6% profit margin and efficient operations. The company's 0.01 debt-to-equity ratio and 25.4% ROE suggest a robust business model, allowing it to generate significant cash flow and invest in growth initiatives. Its position in the internet retail sector provides a foundation for long-term growth and profitability.
Risk. Key risks for PDD include its low beta of 0.03, which may indicate limited upside potential, and its dependence on the internet retail sector, which can be subject to fluctuations in consumer spending. Additionally, the company's 9.7% revenue growth rate, while positive, may be impacted by changes in market trends or increased competition.
Horizon. 1-3 yr $120.43 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $114.28 at ~6% CAGR — dividend + buyback compounding. 10 yr $145.88 if the moat survives secular pressure.
4. BZ — KANZHUN LIMITED · score 97
Internet Content & Information · price $14.10 · 1Y $21.27 · 5Y $18.87 · 10Y $24.08
FCF $683m C+ · Rev +12.4% B+ · D/E 0.01 A · P/E 13.3x B+ · PEG 0.18 A
Why now. KANZHUN LIMITED, an Internet Content & Information company, is currently undervalued with a 13.3 P/E ratio and a 0.18 PEG ratio, indicating a potential for re-rating. The company's 40.1% profit margin and 18.2% ROE suggest a strong business model. With a current price of $14.10 and an analyst consensus 1-yr target of $21.27, there is a significant upside potential.
Moat. KANZHUN LIMITED's durable competitive advantage stems from its high 40.1% profit margin, which is driven by its ability to maintain a strong ROE of 18.2%. The company's low 0.01 debt-to-equity ratio and 683m free cash flow also contribute to its moat, allowing it to invest in growth initiatives and maintain its market position.
Risk. The main risks facing KANZHUN LIMITED include its low 0.48 beta, which may indicate a lack of volatility, but also suggests that the stock may not be as responsive to market movements. Additionally, the company's 12.4% revenue growth rate may be affected by market fluctuations, and its 5.1 PS ratio may be elevated compared to its peers.
Horizon. 1-3 yr $21.27 (analyst consensus (n=21)) — multiple re-rating thesis requires a catalyst. 5 yr $18.87 at ~6% CAGR — dividend + buyback compounding. 10 yr $24.08 if the moat survives secular pressure.
5. ACN — Accenture plc · score 96
Information Technology Services · price $177.43 · 1Y $244.86 · 5Y $237.44 · 10Y $303.08
FCF $12.5b A- · Rev +7.4% B · D/E 0.25 B · P/E 14.5x A- · PEG 1.32 B
Why now. Accenture plc, a leading Information Technology Services provider, is currently undervalued with a 14.5 P/E ratio and a 1.32 PEG ratio, considering its 7.4% revenue growth rate and $12.5b free cash flow. The company's current price of 177.43 presents a buying opportunity, especially with an analyst consensus 1-yr target of 244.86. Accenture's services are in high demand, driven by the need for digital transformation across various industries.
Moat. Accenture's durable competitive advantage stems from its high 24.8% ROE, driven by its pricing power and category leadership in the Information Technology Services sector. The company's 10.6% profit margin and $12.5b free cash flow demonstrate its ability to generate strong cash flows and invest in its business. Additionally, Accenture's 0.25 debt-to-equity ratio provides a solid financial foundation for the company to pursue growth opportunities.
Risk. The main risks facing Accenture include the potential for 7.4% revenue growth to slow down, the impact of a 1.07 beta on the company's stock price during market downturns, and the possibility of increasing competition in the Information Technology Services sector. Furthermore, Accenture's 14.5 P/E ratio may be elevated compared to its historical average, which could lead to a correction in the stock price.
Horizon. 1-3 yr $244.86 (analyst consensus (n=26)) — multiple re-rating thesis requires a catalyst. 5 yr $237.44 at ~6% CAGR — dividend + buyback compounding. 10 yr $303.08 if the moat survives secular pressure.
Speculative — asymmetric upside
1. BILL — BILL Holdings, Inc. · score 88
Software - Application · price $35.20 · 1Y $55.10 · 5Y $70.80 · 10Y $184.23
FCF $327m C · Rev +13.4% B+ · D/E 0.50 B · P/S 2.2x A- · PEG 0.38 A
Why now. BILL Holdings, Inc., a software application company, is currently trading at $35.2 with a 13.4% revenue growth rate and a 0.38 PEG ratio, indicating a high-risk, high-reward setup. The company's free cash flow of $327m and debt-to-equity ratio of 0.5 suggest a stable financial foundation. With an analyst consensus 1-yr target of $55.1, the stock has potential for significant upside.
Moat. BILL's moat lies in its ability to generate $327m in free cash flow, which can be reinvested in the business to drive growth. The company's 2.2 price-to-sales ratio and 0.38 PEG ratio indicate a reasonable valuation for a growth company. Additionally, BILL's 1.22 beta suggests a higher level of volatility, but also potential for greater returns.
Risk. The main risks facing BILL include its 0% profit margin, which indicates a lack of profitability, and its 1.22 beta, which suggests a higher level of volatility. Additionally, the company's 0.5 debt-to-equity ratio, while reasonable, still poses a risk if the company is unable to generate sufficient cash flow to service its debt.
Horizon. 1-3 yr $55.10 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $70.80 — requires the platform / technology to reach commercial scale. 10 yr $184.23 — return distribution heavily skewed.
2. WIX — Wix.com Ltd. · score 88
Software - Infrastructure · price $55.08 · 1Y $86.05 · 5Y $110.78 · 10Y $288.25
FCF $505m C+ · Rev +13.2% B+ · D/E n/a · P/S 1.1x A- · PEG 0.15 A
Why now. Wix.com Ltd., a software infrastructure company, is currently trading at $55.08 with a 13.2% revenue growth rate and a 1.1 price-to-sales ratio, indicating a potential undervaluation. The company's $505m in free cash flow and 0.15 PEG ratio suggest a promising growth trajectory. As a high-risk, high-reward investment, Wix's success hinges on its ability to maintain growth momentum and expand its customer base.
Moat. Wix's competitive advantage lies in its ability to provide a comprehensive platform for users to create and manage online presence, leveraging its 1.01 beta to navigate market fluctuations. The company's focus on software infrastructure allows it to benefit from the sector's inherent scalability and low marginal costs, enabling it to maintain a competitive edge. Additionally, Wix's -2% profit margin suggests room for improvement, which could be driven by operational efficiencies and strategic investments.
Risk. Key risks for Wix include the potential for revenue growth deceleration and increased competition in the software infrastructure sector. The company's null debt-to-equity ratio is not a concern, but its 1.01 beta indicates a relatively high sensitivity to market volatility. Furthermore, Wix's -2% profit margin and null ROE highlight the need for the company to improve its operational efficiency and profitability.
Horizon. 1-3 yr $86.05 (analyst consensus (n=19)) — catalyst-driven; binary events dominate. 5 yr $110.78 — requires the platform / technology to reach commercial scale. 10 yr $288.25 — return distribution heavily skewed.
3. CRC — California Resources Corporation · score 87
Oil & Gas E&P · price $62.20 · 1Y $82.45 · 5Y $125.11 · 10Y $325.54
FCF $778m C+ · Rev +15.1% B+ · D/E 0.47 B · P/S 1.6x B+ · PEG 0.29 A
Why now. California Resources Corporation, an Oil & Gas E&P company, is currently priced at $62.20 with a 15.1% revenue growth rate and a 0.29 PEG ratio, indicating a potential for high-risk, high-reward investment. The company's $778m free cash flow and 0.47 debt-to-equity ratio suggest a relatively stable financial position. As a spec name, CRC's binary setup relies on the success of its oil and gas operations, with a potential upside driven by the $82.45 analyst consensus 1-yr target.
Moat. CRC's moat lies in its ability to generate $778m in free cash flow, which can be used to invest in its operations, reduce debt, or return value to shareholders. The company's 1.6 price-to-sales ratio suggests a relatively low valuation, providing a potential margin of safety for investors. Additionally, CRC's 0.96 beta indicates a relatively low volatility, which can be attractive to investors seeking stable returns.
Risk. The main risks facing CRC include its -13.4% profit margin, which indicates a potential struggle to generate earnings, and its -14.4% return on equity, which suggests a potential issue with the company's ability to generate returns on shareholder capital. Furthermore, the company's 0.47 debt-to-equity ratio, while relatively stable, still poses a risk if the company is unable to manage its debt obligations.
Horizon. 1-3 yr $82.45 (analyst consensus (n=11)) — catalyst-driven; binary events dominate. 5 yr $125.11 — requires the platform / technology to reach commercial scale. 10 yr $325.54 — return distribution heavily skewed.
4. BHC — Bausch Health Companies Inc. · score 85
Drug Manufacturers - Specialty & Generic · price $4.95 · 1Y $7.50 · 5Y $9.96 · 10Y $25.91
FCF $989m C+ · Rev +6.7% C+ · D/E n/a · P/S 0.2x A · PEG 0.01 A
Why now. Bausch Health Companies Inc., a specialty and generic drug manufacturer, is currently trading at $4.95 with a 6.7% revenue growth rate and a 0.2 price-to-sales ratio, indicating potential undervaluation. The company's $989m free cash flow and 0.42 beta suggest a relatively stable financial position. As a high-risk, high-reward investment, BHC's success hinges on its ability to drive growth and improve profitability.
Moat. Bausch Health's moat stems from its position in the specialty and generic drug manufacturing sector, where companies can benefit from regulatory protection and high switching costs for customers. With a 0.01 PEG ratio, the company's growth is relatively inexpensive compared to its peers. BHC's business model, focused on specialty and generic drugs, provides a foundation for potential long-term profitability.
Risk. The main risks facing Bausch Health include its -11.5% profit margin, which indicates significant challenges in achieving profitability, and the potential for regulatory changes that could impact the entire sector. Additionally, the company's 0.42 beta suggests some level of market sensitivity, which could exacerbate potential downturns.
Horizon. 1-3 yr $7.50 (analyst consensus (n=6)) — catalyst-driven; binary events dominate. 5 yr $9.96 — requires the platform / technology to reach commercial scale. 10 yr $25.91 — return distribution heavily skewed.
5. CNC — Centene Corporation · score 84
Healthcare Plans · price $59.55 · 1Y $60.06 · 5Y $119.78 · 10Y $311.67
FCF $7.1b B+ · Rev +19.4% B+ · D/E 0.76 C+ · P/S 0.2x A · PEG 1.14 B+
Why now. Centene Corporation, a Healthcare Plans provider, is currently trading at $59.55 with a 19.4% revenue growth rate and a $7.1b free cash flow. The company's 1.14 PEG ratio indicates a potential for growth. With 17 analysts having a mean 1-yr target of $60.06, the setup seems promising for investors looking for a high-risk, high-reward opportunity in the healthcare sector.
Moat. Centene's business model in the healthcare plans sector provides a competitive advantage through its ability to manage costs and negotiate with providers. The company's 0.2 price-to-sales ratio suggests a relatively low valuation, which could be attractive to investors. Additionally, its 0.76 debt-to-equity ratio indicates a manageable level of debt.
Risk. The main risks for Centene Corporation include its -3.6% profit margin, which indicates a loss-making situation, and its -26% return on equity, which is a significant concern. Furthermore, the company's 1.06 beta suggests a higher level of volatility compared to the market.
Horizon. 1-3 yr $60.06 (analyst consensus (n=17)) — catalyst-driven; binary events dominate. 5 yr $119.78 — requires the platform / technology to reach commercial scale. 10 yr $311.67 — return distribution heavily skewed.
Methodology footnote
Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.